Engine Capital pushes for changes at cancer therapy developer 2seventy bio
(Reuters) -Activist investor Engine Capital on Wednesday sent a letter to the board of cancer therapy developer 2seventy bio, urging a board refresh and the appointment of Chief Operating Officer Chip Baird as CEO, among other changes. Engine Capital, which owns about a 3% stake in 2seventy bio, said the company should exclusively focus on …
Engine Capital pushes for changes at cancer therapy developer 2seventy bio Read More »









